Performance in the Real World Central to New Drug's Success
Time was that getting a new medicine over the goal line equated to receiving the "green light" for approval from the FDA. In today's environment of government austerity measures and shrinking health care budgets, however, a drug's approval now only represents a "first and goal." To achieve a "touchdown" drug developers are going to have to demonstrate favorable pharmacoeconomics and real-world value for their products.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter